Over half of payers had at least one outcomes-based contract in 2022, according to a survey from Avalere.
The survey, published April 5, asked 46 health plans about their use of and attitudes toward value-based contracts. Of the payers surveyed, 58 percent said they had at least one outcomes-based contract in 2022, and 35 percent had more than 10 outcomes-based contracts.
Around 15 percent of payers surveyed said they are in negotiations or planning to undertake outcomes-based contracts.
Oncology, cardiology and endocrinology were the most common therapeutic areas where payers entered outcomes-based contracts, the survey found.
Around three in four payers with outcomes-based contracts said they prefer contracts that include both claims-based and clinical-based outcomes.
See the full survey here.